Chemical Structure : AZD4573
CAS No.: 2057509-72-3
Catalog No.: PC-35250Not For Human Use, Lab Use Only.
AZD4573 (AZD-4573) is a potent and selective inhibitor of CDK9 with IC50 of <4 nM, with fast-off binding kinetics and high selectivity versus other kinases, including other CDK family kinases.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $128 | In stock | |
10 mg | $198 | In stock | |
25 mg | $328 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
AZD4573 (AZD-4573) is a potent and selective inhibitor of CDK9 with IC50 of <4 nM, with fast-off binding kinetics and high selectivity versus other kinases, including other CDK family kinases.
AZD4573 exhibits a short half-life in multiple preclinical species and good solubility for intravenous administration.
AZD4573 dose- and time-dependently decreases cellular pSer2-RNAPII, resulting in activation of caspase 3 and cell apoptosis in a broad range of haematological cancer cell lines.
AZD4573 demonstrates in vivo efficacyin xenograft models derived from multiple haematological tumours.
M.Wt | 429.949 | |
Formula | C22H28ClN5O2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(1S,3R)-3-acetamido-N-(5-chloro-4-(5,5-dimethyl-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)pyridin-2-yl)cyclohexane-1-carboxamide |
1, Cidado J, et al. Clin Cancer Res. 2019 Nov 7. pii: clincanres.1853.2019.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright